Cargando…
What’s new in neuromuscular pathology 2022: myopathy updates and gene therapies
This compilation of new changes in the diagnosis and treatment of muscle and nerve disease is extracted from the latest publications from the European Neuromuscular Centre International workshops, FDA.gov and clinicaltrials.gov.
Autor principal: | Cai, Chunyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists/The Korean Society for Cytopathology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846006/ https://www.ncbi.nlm.nih.gov/pubmed/36535762 http://dx.doi.org/10.4132/jptm.2022.10.14 |
Ejemplares similares
-
What’s new in breast pathology 2022: WHO 5th edition and biomarker updates
por: Muller, Kristen, et al.
Publicado: (2022) -
What’s new in kidney tumor pathology 2022: WHO 5th edition updates
por: Tretiakova, Maria
Publicado: (2022) -
What’s new in soft tissue and bone pathology 2022–updates from the WHO classification 5th edition
por: Kao, Erica Y., et al.
Publicado: (2022) -
What’s new in molecular genetic pathology 2022: immune checkpoint inhibitor biomarkers and select solid tumors
por: Tsang, Patricia C., et al.
Publicado: (2022) -
What’s New in Pathology Newsletter by PathologyOutlines.com
por: Pernick, Nat
Publicado: (2021)